Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-22

Study Completion Date

2024-05-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial tests how well a pain management intervention preparatory to a future pragmatic trial works in rural dwelling and Hispanic cancer survivors. Cancer pain is a key case study in health disparities in the United States. Cancer pain is prevalent, under treated, and remains a major cause of suffering, impairment, and disability for millions of Americans. Individual pain interventions and care models show promise for cancer pain in controlled settings. Hispanic and rural-dwelling cancer survivors stand to benefit the most from electronic health record innovations, as each of these health disparities populations experience profound disparities in pain outcomes, including marked under- and over-prescribing of opioids. Additionally, Hispanics not only comprise a steadily growing proportion of cancer survivors, but are also increasingly immigrating to rural communities, potentially placing them at "double risk" for poor outcomes. This trial will allow for the refinement of pain management intervention components that could help the management of cancer-related pain in rural dwelling and Hispanic cancer survivors.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors (ASCENT)

NCT06198010

Hematopoietic and Lymphoid System Neoplasm Malignant Solid Neoplasm Hematopoietic and Lymphatic System Neoplasm

RECRUITING NA

An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors

NCT06062901

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

COMPLETED NA

A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota

NCT07291011

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

RECRUITING NA

Improving Pain Management in Patients With Nonhematologic Cancer

NCT00036829

Pain Unspecified Adult Solid Tumor, Protocol Specific

COMPLETED NA

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

NCT05969860

Advanced Vaginal Carcinoma Advanced Anal Carcinoma Advanced Biliary Tract Carcinoma +40 more

RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVE:

I. To refine and pilot test components of a validated collaborative care model-based intervention aimed at improving pain control among rural dwelling and Hispanic cancer survivors.

GROUP I: Participants meet with pain care manager (PCM) and community health worker (CHW) via telephone or video visit to discuss the cancer-related pain. Participants receive self-guided pain management education materials and receive an action plan with suggestions or referrals to participate in tier 1 interventions that include exercise, cognitive behavioral therapy, medication and/or tier 2 interventions that include integrative medicine (massage, acupuncture and mindfulness relaxation), spiritual support, pain clinic referral and palliative and spiritual care referrals during the intake visit. Participants undergo a planning visit 2 weeks later to give an update on their pain and may receive additional resources from the PCM and/or CHW. Participants then undergo a final visit 4 weeks later with the PCM and/or CHW and receive final recommendations and referrals. Participants may receive a follow up call between intake and visit 2 and/or between visit 2 and the final visit from the CHW or PCM to assess pain levels on study.

GROUP II: ASCENT study interventionists complete an interview on study.

GROUP III: Medical oncology providers participate in a focus group on study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Leukemia Hematopoietic and Lymphoid System Neoplasm Lymphoma Malignant Solid Neoplasm Multiple Myeloma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Inclusion Criteria

* A qualifying liquid or solid cancer diagnosis with visits at a participating Mayo site
* Age 18+
* Numerical rating scale (NRS) pain score of a 5+ out of 10
* Pain that developed (onset) or significantly worsened since cancer diagnosis
* Malignant hematology including:

* Lymphoma
* Myeloma
* Chronic leukemias

Exclusion Criteria

* Patient Health Questionnaire (PHQ) 8 score of 10 or more
* Life expectancy less than 12 months
* Hospice enrollment
* Admitted to hospital from long term care/skilled nursing facilities (SNF)
* Acute leukemias
* Primary brain tumors
* Confinement to a bed or a chair more than a third of waking hours because of health complications

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No